The road from lab to clinic
CAR T-cell therapies offer an exciting new way to treat cancer. The NRC is working with academic, clinical and industry researchers to develop cutting-edge, made-in-Canada CAR T-cell therapies—and focusing on making these new treatments affordable and accessible to Canadian patients.
We're putting the spotlight on CAR T-cell therapy, from it being a medical innovation to a treatment available for actual cancer patients, including how it works, who could benefit from it and what's needed before it'll be ready for use in humans.
